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Introduction {#sec005}
============

Cardiovascular morbidity and mortality remain exceptionally high in maintenance hemodialysis (HD) patients. Autonomic dysfunction (AD) is highly prevalent in end-stage renal disease patients undergoing HD treatment \[[@pone.0128123.ref001]\] and has been implicated in the increased risk of sudden death in this population \[[@pone.0128123.ref002]\]. Studies in dialysis patients have consistently demonstrated a poor autonomic function which is associated with increased mortality rate \[[@pone.0128123.ref003],[@pone.0128123.ref004]\]. The 24h-Holter is the most frequent method to evaluated AD. The exercise treadmill test (ETT) has mainly been used to evaluate cardiorespiratory fitness in this population but it also allows measurement of changes in heart rate (HR) under physical stress and can be used to assess autonomic function \[[@pone.0128123.ref005]--[@pone.0128123.ref008]\]. On the other side, HD patients have high levels of inflammatory markers such as C-reactive protein, which have also been associated with autonomic dysfunction and increased risk of mortality \[[@pone.0128123.ref008],[@pone.0128123.ref009]\].

The aim of this study was to evaluate the ability of different parameters of ETT to detect AD in maintenance HD patients.

Methods {#sec006}
=======

Study population {#sec007}
----------------

We conducted a cross-sectional study with end stage renal disease patients on HD 3 times a week (4-hour duration sessions), for at least 3 months and a control group matched by gender and age without overt kidney disease. Hemodialysis patients were recruited from a single dialysis center and the control group consisted of individuals referred for exercise testing at the University Hospital. Written informed consent was obtained and approved, as well the protocol of study, by the ethical committee of the medical school (Comitê de Ética em Pesquisa da Faculdade de Medicina da Universidade Federal Fluminense---Hospital Universitário Antonio Pedro, n°: CAAE: 0125.0258.000--10). Chronic medications, including those for blood pressure control, were not discontinued during the study.

Exclusion criteria were as follow: impaired gait that prevented walking on the treadmill, arrhythmias preventing proper assessment of heart rate, and the presence of symptomatic heart disease. Cardiac evaluation was always accomplished in a middle of week in non-dialytic day and consisted of: clinical examination, transthoracic echocardiogram, 24-h Holter, and ETT in the interdialytic period.

Echocardiography {#sec008}
----------------

A two-dimensional transthoracic echocardiography was performed with GE VIVID 7 System (General Electric Company, USA) to assess left ventricle wall motion and systolic and diastolic ventricular function.

24h-Holter {#sec009}
----------

Patients underwent a 24h-Holter (Galix Biomedical Instrumentation, Florida, USA). A 3-channel recorder was used to record the electrocardiographic traces. A time domain analysis of HRV was performed and the following parameters were obtained: a) SDNN, standard deviation (SD) of all normal RR intervals (NN); b) SDANN, SD of the averages of 5-min NN intervals over 24-h; c) rMSSD, the square root of the mean of the square of successive NN intervals; and d) triangular index (TI), integral of the density distribution (that is, the number of all NN intervals) divided by the maximum density distribution.

Cutoff values adopted in the present study were derived from a previous study in which SDNN \<50 msec, SDANN \<40 msec, rMSSD \<15 msec, and TI \<15 were definitely associated with increased cardiovascular mortality in HD patients \[[@pone.0128123.ref010]\].

Exercise treadmill test {#sec010}
-----------------------

Patients underwent ETT on a treadmill ramp protocol using the program Ergo13 (Heart Ware Co., Minas Gerais, Brazil). The test was symptom limited, scheduled for ten minutes with active recovery for 2 minutes under 40% of the speed and incline of peak effort. An automatic electrocardiogram was recorded in 13 simultaneous leads before exercise in supine and in standing, at peak exercise, and at every minute of recovery. The following HR related to ETT parameters of AD were analyzed: chronotropic index, heart rate recovery (HRR) at 1^st^, 2^nd^, 3^rd^, 4^th^ and 5^th^min, resting HR/HRR index and HRV (SDNN and rMSSD) during exercise and at the recovery period. The predicted maximal VO~2~ in ramp protocol was reduced by 20% in HD patients. The maximal VO~2~ peak exercise was obtained by the Foster formula backed with hands. The functional aerobic impairment was calculated using the formula: maximum predicted VO~2~--peak VO~2~) / maximal predicted VO~2~\] x100. The predicted maximal HR was calculating by: 208--(0.7 x age). Chronotropic index was calculated as: \[peak HR-resting HR\] / \[(max predicted HR---resting HR\]. Chronotropic incompetence was said to be present when values of chronotropic index were \<0.80 (or \<0.62 if in use of betablocker) \[[@pone.0128123.ref011],[@pone.0128123.ref012]\]. The HRR was calculated from the absolute differences between peak HR values and the HR values in every minute of recovery. Values in HRR at 1^st^min \>12 bpm and at 2^nd^min \>22bpm were considered abnormal \[[@pone.0128123.ref013]\]. The resting HR/HRR index was calculated as (resting HR-HRR)/RHR and values above 0.72 were considered abnormal \[[@pone.0128123.ref014]\]. Heart rate variability in ETT was obtained by software specially designed for the study conveying electrocardiographic data findings of Ergo13 for Cardio Smart (Cardios, São Paulo, Brazil) during exercise and recovery periods separately.

Blood analysis {#sec011}
--------------

Blood samples were performed 30 min before the exercise test for determination of ultrasensitive C-reactive protein in both groups and creatinine in control group (to exclude overt renal disease). C-reactive protein was obtained by a immunoturbidimetric assay (Dimension RxLMax, Siemens, Berlin, Germany).

Statistics {#sec012}
----------

Results were expressed as mean and SD for normal distribution and median and range otherwise. Categorical variables were expressed as frequencies and compared using the Chi-square test. Comparisons between two continuous variables were accomplished by the t test (for normal distribution) or its nonparametric equivalent (Mann-Whitney test). Logistic regression was used to analyze associations. P\<0.05 was considered significant. Analyses were performed using SPSS for Windows version 18.0 (SPSS Inc., Chicago, IL, USA).

Results {#sec013}
=======

A total of 125 patients from a single dialysis center were initially evaluated. Nine were promptly excluded due to gait impairment. Of the 116 remaining, 59 agreed to participate and signed the consent form. Eighteen patients were excluded: 10 did not show up for the exams, 4 had a past myocardial infarction, 2 had arrhythmia, 1 had bilateral fistula, and 1 had current pulmonary infection. At the end, 41 HD patients concluded the study. The most common etiologies of the renal disease were: hypertensive nephrosclerosis (56%), chronic glomerulonephritis (17%), polycystic kidney (10%), and diabetic nephropathy (7%). The general features of patients and controls are in [Table 1](#pone.0128123.t001){ref-type="table"}.

10.1371/journal.pone.0128123.t001

###### General features of patients.

![](pone.0128123.t001){#pone.0128123.t001g}

                                       HD patients                                       Controls      P value
  ------------------------------------ ------------------------------------------------- ------------- ---------
  Age, years                           50 ± 14[^a^](#t001fn002){ref-type="table-fn"}     50 ± 13       0.975
  Male, %                              21 (51.2)[^b^](#t001fn003){ref-type="table-fn"}   21 (51.2)     1.000
  Race, non-white %                    27 (65.9)                                         21 (51.2)     0.391
  Body mass index, kg/m^2^             25.1 ± 5.1                                        27.3 ± 4.1    0.030
  HD vintage, months                   67.2 ± 47.3                                       n.a.          \-
  Diabetes, %                          4 (9.8)                                           5 (12.2)      0.724
  Smoking, %                           3 (9.1)                                           8 (20.5)      0.180
  Familial CAD,%                       15 (36.6)                                         17 (41.5)     0.520
  Familial hypertension, %             26 (63.4)                                         21 (51.2)     0.525
  Sedentary, %                         33 (80.5)                                         24 (58.5)     0.031
  Use of blood pressure drugs, %       33 (80.5)                                         20 (48.8)     0.003
   Beta-blocker                        14 (34.1)                                         7 (17.1)      0.077
   Diuretic                            2 (4.9)                                           8 (19.5)      0.043
   Calcium channel blocker             5 (12.2)                                          2 (4.9)       0.236
   ACE inhibitor/ARB                   12 (29.3)                                         16 (39.0)     0.352
   Clonidine                           8 (19.5)                                          \-            0.003
   Alfa-blocker                        6 (14.6)                                          \-            0.011
  C-reactive protein, mg/dL            1.02 ± 1.20                                       0.47 ± 0.07   0.010
  Hemoglobin, g/dL                     11.5±1.4                                          13.8±1.2      \<0.001
  eGFR (MDRD study), ml/min/1.73m^2^   n.a.                                              87.5 ± 23.1   \-

ACE, angiotensin-converting---enzyme; ARB, AT1--receptor blocker; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate; HD, hemodialysis; MDRD, modification of diet in renal disease; n.a., non-applicable.

^a^ Mean ± S.D.;

^b^ n (%).

Systolic function of the left ventricle, as analyzed by the ejection fraction at the echocardiogram, was similar between groups (66.1±10.1% *vs*. 68.6±5.4% for HD patients and controls, respectively, P = 0.167) but diastolic dysfunction was more prevalent in HD patients (77% *vs*. 42%, P = 0.004).

There was no difference between HD and control groups in relation to pre-exercise test parameters (HR = 77±12bpm *vs*. 76±13bpm, p = 0.705; systolic blood pressure = 131±39mmHg *vs*. 130±31mmHg, p = 0.860; and diastolic blood pressure = 82±11mmHg *vs*. 83±9mmHg, p = 0.135).

No complications occurred during ETT in HD patients. Reasons for stopping the exercise were: general exhaustion, 80.5%, exhaustion of the lower limbs muscle, 4.9%, left bundle branch block of high-grade, 2.4%, arrhythmia, 2.4%, and hypertension, 2.4%. Cardiorespiratory fitness parameters were significantly different between groups. Hemodialysis patients exhibited lower MET (6.9±2.0 *vs*. 9.5±2.5, p\<0.001) and higher functional aerobic impairment (29.5±12.0 *vs*. 2.8±20.1, p\<0.001).

Differences were observed regarding the mean values of HR related parameters in ETT between groups. Hemodialysis patients exhibited lower chronotropic index, reduced HRR at 1^st^, 2^nd^, 3^rd^, 4^th^, and 5^th^ min, higher resting HR/HRR index, and reduced HRV during exercise and recovery ([Table 2](#pone.0128123.t002){ref-type="table"}).

10.1371/journal.pone.0128123.t002

###### Mean and standard deviation of heart rate related autonomic dysfunction parameters in 24-h Holter and exercise treadmill test.

![](pone.0128123.t002){#pone.0128123.t002g}

                            HD patients   Controls       P value
  ------------------------- ------------- -------------- ---------
  24h-Holter                                             
   SDNN, msec               82.6 ± 27.6   119.1 ± 47.6   \<0.001
   SDANN, msec              74.3 ± 26.8   113.1 ± 43.2   \<0.001
   rMSSD, msec              17.4 ± 7.7    27.6 ± 11.1    \<0.001
   TI, msec                 23.3 ± 8.4    34.4 ± 9.3     \<0.001
  Exercise treadmill test                                
   Chronotropic index       0.58 ± 0.19   0.89 ± 0.12    \<0.001
   HRR 1^st^ min, bpm       11.9 ± 9.1    19.4 ± 8.6     \<0.001
   HRR 2^nd^ min, bpm       21.3 ± 12.3   33.9 ± 10.5    \<0.001
   HRR 3^rd^ min, bpm       33.8 ± 21.3   53.3 ± 18.0    \<0.001
   HRR 4^th^ min, bpm       38.3 ± 21.9   58.0 ± 15.7    \<0.001
   HRR 5^th^ min, bpm       40.8 ± 21.3   60.3 ± 14.4    \<0.001
   Resting HR/HRR index     0.80 ± 0.19   0.69 ± 0.18    0.008
   SDNN exercise, msec      33.7 ± 14.2   50.0 ± 21.8    \<0.001
   rMSSD exercise, msec     11.0 ± 5.5    15.3 ± 14.7    0.092
   SDNN recovery, msec      20.1 ± 9.8    27.3 ± 17.4    0.024
   rMSSD recovery, msec     11.5 ± 7.8    15.4 ± 17.3    0.196

HR, Heart rate; HRR, Heart rate variation in recovery; TI, triangular index

In general, the frequency of abnormal results denoting AD tended to be higher in HD patients in both ETT and 24h-Holter ([Table 3](#pone.0128123.t003){ref-type="table"}). The parameters with the best performance to discriminate the two groups at the ETT during exercise (chronotropic index) and recovery (HRR 1^st^min), and the HRV (SDNN exercise) were used to develop an AD score using cutoffs of previous studies \[[@pone.0128123.ref010],[@pone.0128123.ref015],[@pone.0128123.ref016]\]. The number of points in the AD score in controls and HD patients are depicted in [Fig 1](#pone.0128123.g001){ref-type="fig"}.

10.1371/journal.pone.0128123.t003

###### Frequency of abnormal values in selected parameters of autonomic function at the 24h-Holter and exercise treadmill test.

![](pone.0128123.t003){#pone.0128123.t003g}

                                                                       HD patients N (%)   Controls N (%)   OR (95% CI)         P value
  -------------------------------------------------------------------- ------------------- ---------------- ------------------- ---------
  24h-Holter                                                                                                                    
   SDNN \<50 msec                                                      5 (12.2)            4 (9.8)          \-                  0.693
   SDANN \<40 msec                                                     5 (12.2)            3 (7.3)          \-                  0.433
   rMSSD \<15 msec                                                     20 (48.8)           3 (7.3)          13.0 (3.4--49.3)    \<0.001
   TI \<15                                                             7 (17.1)            1 (2.4)          8.5 (1--73.0)       0.050
  Exercise treadmill test                                                                                                       
   Altered chronotropic index [^a^](#t003fn002){ref-type="table-fn"}   33 (80.5)           5 (12.2)         29.7 (8.9--100.0)   \<0.001
   HRR 1^st^ min. bpm \<12 bpm                                         23 (56.1)           3 (7.3)          19.0 (5.0--72.2)    \<0.001
   HRR 2^nd^ min. bpm \<22 bpm                                         23 (56.1)           5 (12.2)         10.8 (3.5--33.4)    \<0.001
   Resting HR/HRR Index \<0.72                                         30 (73.2)           22 (53.7)        8.5 (1.0--73.0)     0.050
   SDNN exercise \<50 msec                                             34 (82.9)           23 (56.1)        6.*7* (2.0--22.2)   0.002
   rMSSD exercise \<15 msec                                            30 (73.2)           31 (75.6)        \-                  0.724
   SDNN recovery \<50 msec                                             38 (92.7)           37 (90.2)        \-                  0.184
   rMSSD recovery \<15 msec                                            32 (78.0)           29 (70.7)        \-                  0.333

HR, heart rate; HRR, heart rate variation in recovery; TI, triangular index.

^a^ values \<0.80 for no betablocker use and \<0.62 in use of betablocker. Odds ratio were only showed if P\<0.05.

![Autonomic dysfunction score.\
Number of cases with 0, 1, 2, and 3 points in the exercise treadmill test autonomic dysfunction score in controls and hemodialysis patients. Parameters that composed the autonomic dysfunction score were: chronotropic index, heart rate recovery in 1^st^ min and SDNN exercise (one point for each abnormal test). HD, hemodialysis.](pone.0128123.g001){#pone.0128123.g001}

The most discriminative parameter between HD and control groups in ETT (the chronotropic index), and the AD scoring were used as the dependent variables to test associations with the primary interest variable of our study, "hemodialysis". In every multivariate logistic regression models tested, hemodialysis was independently associated with either altered chronotropic index or AD scoring ≥2. The initial association of HD with the rMSSD in 24h-Holter was no longer present after adjustments (OR = 5.5, P = 0.190, model 5), [Table 4](#pone.0128123.t004){ref-type="table"}.

10.1371/journal.pone.0128123.t004

###### Crude and adjusted odds ratios in different multivariate analysis models to test associations of hemodialysis treatment with either abnormal rMSSD at the 24h-Holter, or chronotropic index and autonomic dysfunction score ≥ 2 at the exercise treadmill test.

![](pone.0128123.t004){#pone.0128123.t004g}

            rMSSD at 24h-holter                                      Chronotropic index at ETT                                     AD score ≥ 2 at ETT
  --------- -------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------
  Crude     13.0 (3.4--49.3) [‡](#t004fn003){ref-type="table-fn"}    29.7 (8.9--100,0) [‡](#t004fn003){ref-type="table-fn"}        20.0 (6.5--61.5) [‡](#t004fn003){ref-type="table-fn"}
  Model 1   13.3 (3.5--50.6) [‡](#t004fn003){ref-type="table-fn"}    44.9 (10.6--190.0) [‡](#t004fn003){ref-type="table-fn"}       26.7 (7.6--94.7) [‡](#t004fn003){ref-type="table-fn"}
  Model 2   18.8 (3.8--92.7) [‡](#t004fn003){ref-type="table-fn"}    80.7 (13.3--492.1) [‡](#t004fn003){ref-type="table-fn"}       86.3 (12.5--596.5) [‡](#t004fn003){ref-type="table-fn"}
  Model 3   19.0 (3.6--100.1) [†](#t004fn002){ref-type="table-fn"}   134.8 (15.5--1175.1) [‡](#t004fn003){ref-type="table-fn"}     235.9 (18.5--3012.8) [‡](#t004fn003){ref-type="table-fn"}
  Model 4   4.2 (0.6--32.9)                                          146.2.0 (11.7--1832.5) [‡](#t004fn003){ref-type="table-fn"}   687.5 (18.6--25473.2) [‡](#t004fn003){ref-type="table-fn"}
  Model 5   5.5 (0.4--71.1)                                          50.1 (3.9--641.6) [†](#t004fn002){ref-type="table-fn"}        270.9 (7.2--10182.7) [†](#t004fn002){ref-type="table-fn"}

Models consisted of progressive inclusion of following confounding factors: age, and gender (model 1); smoking, body mass index, and sedentary (model 2); diabetes, clonidine and betablocker use (model 3); hemoglobin, and serum C-reactive protein (model 4); and functional aerobic impairment (model 5). AD, autonomic dysfunction; ETT, exercise treadmill test. \*P\<0.05,

^†^P\<0.01,

^‡^P\<0.001.

Finally, in HD patients, C-reactive protein correlated with a number of parameters in ETT, namely, HRR at 1^st^ (r = -0.381, P = 0.017) and 2^nd^ minutes (r = -0.382, P = 0.016), resting HR/HRR index (r = 0.355, P = 0.027), SDNN exercise (r = -0.351, P = 0.033) and the AD score (r = 0.318, P = 0.046). There was no correlation between C-reactive protein and parameters assessing HRV at 24h-Holter.

Discussion {#sec014}
==========

Autonomic dysfunction is a frequent abnormality in HD patients and a marker of cardiovascular events and death \[[@pone.0128123.ref004],[@pone.0128123.ref010],[@pone.0128123.ref017],[@pone.0128123.ref018]\]. The ETT, a valuable tool to assess AD, is hardly used in HD patients.

We studied the ability of different autonomic parameters during ETT to diagnose AD in HD patients in comparison to a control group and compared the findings in ETT with the ones of the 24-h Holter.

The functional capacity, as analyzed by MET was lower in HD group, a finding already well documented in HD patients \[[@pone.0128123.ref019],[@pone.0128123.ref020]\].

In our sample, body mass index was in the limit of overweight in HD patients and clearly in that range in the control group. This is not unexpected considering that under nutrition was common in HD patients in the past \[[@pone.0128123.ref021]\] but not in the present and that obesity is a recognized risk factor for cardiovascular diseases \[[@pone.0128123.ref022],[@pone.0128123.ref023]\]. The proportion of *diabetes mellitus* in our sample was lower than the ones reported in the international series \[[@pone.0128123.ref024]--[@pone.0128123.ref026]\], and even lower than the one reported for the Brazilian dialysis population \[[@pone.0128123.ref027]\] probably as a result of the inclusion and exclusion criteria adopted in the study. Diabetic patients are known to have more disautonomia than no diabetic ones; this fact led us to include diabetes as a confounding factor in the multivariate logistic regression models. In support to the majority of reported series \[[@pone.0128123.ref001],[@pone.0128123.ref024]--[@pone.0128123.ref026]\], a substantial number of the HD patients were in use of blood pressure drugs. Consistent with the concept that sympathetic overactivity may play an important role in the hypertension of chronic kidney disease patients, drugs mainly affecting this pathway were more frequently prescribed for HD patients \[[@pone.0128123.ref027]\]. In addition, serum levels of C-reactive protein were statistically higher in HD patients, who are well recognized as portraying a chronic inflammatory state \[[@pone.0128123.ref028],[@pone.0128123.ref029]\].

Consistent with previous reports \[[@pone.0128123.ref030],[@pone.0128123.ref031]\], left diastolic dysfunction at the echocardiogram was more frequent in HD patients. In contrast, left ventricular systolic function was similar in both groups perhaps due to our enrollment criteria, which excluded patients with overt heart failure to participate.

Low HRV has been associated with reduced survival in the HD population \[[@pone.0128123.ref003],[@pone.0128123.ref010],[@pone.0128123.ref017]\]. In agreement with previous studies, HRV in the 24-h Holter was lower in the studied HD patients denoting impaired autonomic function \[[@pone.0128123.ref003],[@pone.0128123.ref004],[@pone.0128123.ref010],[@pone.0128123.ref017],[@pone.0128123.ref032]\].

When analyzing HR related parameters in ETT, considerable differences were found between groups. We observed higher frequency of chronotropic incompetence in HD patients. An attenuated HR response to exercise has been shown to predict adverse cardiac events in subjects without overt cardiovascular disease \[[@pone.0128123.ref016]\].Reduced HR response to exercise also predicts major adverse cardiac events among persons with overt or suspected cardiovascular disease even after adjusting for left ventricular function and the severity of exercise-induced myocardial ischemia \[[@pone.0128123.ref033]\]. In heart failure patients it can be an important cause of exercise intolerance, and in patients not taking beta-blockers, the presence of chronotropic incompetence appears to increase the mortality risk \[[@pone.0128123.ref005],[@pone.0128123.ref006]\]. Khan et al \[[@pone.0128123.ref012]\] followed 3790 middle-aged individuals on beta-blockers referred for exercise testing for 4.5 years and, after adjusting for different variables, found that chronotropic index\<0.62 was a strong independent predictor of mortality. The initial exercise-induced increase in HR mainly depends on the vagal withdrawal, whereas further increases in increments depend on the sympathetic activity according to the intensity of exercise \[[@pone.0128123.ref034]\]. Findings for the present study can be accounted for by the hyperadrenergic state characteristic of HD but also present in heart failure \[[@pone.0128123.ref007]\], which can lead to compensatory vagal hyperactivity. This in turn could provide inadequate vagal withdrawal during exercise and changes in baroreflex response, hindering the increase in HR in response to exercise \[[@pone.0128123.ref007],[@pone.0128123.ref035]\]. In other words, despite the tonic increased sympathetic activity, HD patients have reduced phasic autonomic modulation, a well-recognized risk factor.

In our results HRR was significantly lower in HD group in every minute of recovery. Slow recovery of HR post-exercise reflects an inadequate return of cardiac vagal activity, and has proved to be a good marker of cardiovascular events in both heart disease patients and in healthy individuals \[[@pone.0128123.ref036],[@pone.0128123.ref037]\], and also such as a predictor of mortality, independently of the angiographic severity of coronary disease \[[@pone.0128123.ref038]\]. Reduced HRR had already been reported in chronic kidney disease patients far before renal replacement therapy \[[@pone.0128123.ref039]\] consistent with the knowledge that the sympathetic hyperactivity starts early in the course of chronic kidney disease \[[@pone.0128123.ref030]\]. In a study using MIBG scintigraphy in heart failure patients an abnormal HRR was found in patients with high washout rate compared with the normal washout ones again suggesting that adrenergic activation may influence the HRR \[[@pone.0128123.ref040]\].

SDNN during ETT was significantly lower in HD patients at exercise and recovery. Our findings again may reflect the hyperadrenergic state characteristic of HD patients since SDNN represents a general evaluation of autonomic nervous system balance, which depends on modulation by the sympathetic and parasympathetic branches \[[@pone.0128123.ref010]\]. Accordingly, the resting HR/HRR index was higher in HD patients than controls. In normal subjects, the resting HR/HRR index, a cardiac autonomic imbalance index, has been directly associated with inflammation and age, and inversely with physical ability \[[@pone.0128123.ref014]\]. In contrast, the variable predominantly affected by the parasympathetic branch, rMSSD, was not different between groups.

When using cutoffs of greater cardiovascular risk to parameters, we found the ETT was pivotal in identifying dysautonomia in HD patients exhibiting a great ability to discriminate the two groups. In this regard, the higher O.R. values were found for the chronotropic index, and HRR 1^st^min, parameters that are well-recognized as useful tools for the diagnosis of AD at other settings \[[@pone.0128123.ref005],[@pone.0128123.ref006],[@pone.0128123.ref011],[@pone.0128123.ref015]\].

The presence of more than one abnormal parameter in ETT reinforces the probability of a perturbation in the autonomic system \[[@pone.0128123.ref006]\]. In a previous study \[[@pone.0128123.ref006]\], chronotropic incompetence as well as HRR predicts cardiovascular mortality in patients without renal disease referred for exercise testing. Chronotropic incompetence was a stronger predictor of cardiovascular mortality than HRR, but risk was higher if the two abnormalities were simultaneously present. When we applied a score that comprised alterations in three different tests in ETT to our sample, we found that maximal scoring was only observed in HD patients suggesting that these patients may carry a higher risk of mortality.

To better explore the relationship between HD and AD parameters we resort to a variety of models of logistic regression. HD was independently associated with chronotropic incompetence in every tested model including the one in which the functional aerobic impairment was inserted as a controlling variable. Interestingly, the association of hemodialysis with an AD scoring ≥2 was stronger suggesting that this variable portrays the best ability to detect AD in this setting. At this point, it would be convenient to address the issue of over diagnosis of AD by the ETT. The question cannot be definitely answered by our study due to its cross sectional nature, without hard endpoints. However, C-reactive protein levels, which reflect microinflammation, were only associated with parameters measured at the ETT allowing us to think that the findings at the ETT may indeed be clinically relevant. The apparent superiority of the ETT in comparison to the 24h-Holter did not come as a surprise. It is conceivable that the stress faced during exercise imposes substantial requirements to the autonomic system that can surface perturbations that otherwise would remain undetectable.

Reduced number of patients is a limitation of our study that recruited patients from a single center of dialysis. In view of that, our findings need to be confirmed in larger longitudinal studies.

In conclusion, the ETT was feasible and useful to diagnose AD in HD patients. Among the parameters studied, the chronotropic index and the AD score identifying a higher number of affected patients. Findings at ETT correlated with the levels of C-reactive protein suggest that the detected abnormalities may reflect true AD. A larger longitudinal study is necessary to confirm our findings and better evaluate its predictive value.
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